Michael Abern
Impact in
- Surgery top 10%
- Bladder and Urothelial Cancer Treatments
-
- Cancer Immunotherapy and Biomarkers
Papers in
-
- Prostate Cancer Diagnosis and Treatment 2
- Renal cell carcinoma treatment 2
- Prostate Cancer Treatment and Research 1
- Surgery 4
- Bladder and Urothelial Cancer Treatments 3
- Teratomas and Epidermoid Cysts 1
- Co-authors
- Steven A. Garzon (1 shared paper)Suman Setty (1 shared paper)Belinda L. Sun (1 shared paper)Tanya Barauskas Dorff (1 shared paper)Vérane Achard (1 shared paper)Abraham Ami Sidi (1 shared paper)Thomas Zilli (1 shared paper)Matvey Tsivian (1 shared paper)
- Journals
- Journal of the National Comprehensive Cancer Network (2 papers)The Journal of Urology (2 papers)Journal of Endourology (1 paper)Prostate Cancer and Prostatic Diseases (1 paper)British Journal of Urology (1 paper)
- Partner nations
- United StatesGermanyJapan
In The Last Decade
Michael Abern
9 papers receiving 402 citations
Michael Abern's Hit Papers
Peers
Comparison fields: 5 of 36
- Surgery 297
- Oncology 29
- Pulmonary and Respiratory Medicine 40
- Cancer Research 15
- Radiology, Nuclear Medicine and Imaging 24
Countries citing papers authored by Michael Abern
This map shows the geographic impact of Michael Abern's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael Abern with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael Abern more than expected).
Fields of papers citing papers by Michael Abern
This network shows the impact of papers produced by Michael Abern. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael Abern. The network helps show where Michael Abern may publish in the future.
Co-authors
The 25 scholars most cited alongside Michael Abern, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | NCCN Guidelines® Insights: Bladder Cancer, Version 2.2022 Hit paper breakdown → | 2022 | 233 |
| 2 | Bladder Cancer, Version 3.2024 Hit paper breakdown → | 2024 | 138 |
| 3 | 2014 | 11 | |
| 4 | 2023 | 9 | |
| 5 | 2012 | 6 | |
| 6 | 2023 | 5 | |
| 7 | 2022 | 2 | |
| 8 | 2024 | 2 | |
| 9 | 2011 | 1 | |
| 10 | 2011 | 0 |
About Michael Abern
Michael Abern is a scholar working on Pulmonary and Respiratory Medicine, Surgery, Epidemiology, Nuclear Energy and Engineering and Waste Management and Disposal, having authored 10 papers that have together received 407 indexed citations. Recurring topics across this work include Bladder and Urothelial Cancer Treatments (3 papers), Prostate Cancer Diagnosis and Treatment (2 papers), Renal cell carcinoma treatment (2 papers), Teratomas and Epidermoid Cysts (1 paper), Prostate Cancer Treatment and Research (1 paper) and Multiple and Secondary Primary Cancers (1 paper). The work is most often cited by research in Surgery (297 citations), Oncology (29 citations), Pulmonary and Respiratory Medicine (40 citations), Cancer Research (15 citations) and Radiology, Nuclear Medicine and Imaging (24 citations). Michael Abern has collaborated with scholars based in United States, Germany and Japan. Frequent co-authors include Steven A. Garzon, Suman Setty, Belinda L. Sun, Tanya Barauskas Dorff, Vérane Achard, Abraham Ami Sidi, Thomas Zilli, Matvey Tsivian, Alexander Tsivian and Jason M Frerich. Their work appears in journals such as Journal of the National Comprehensive Cancer Network, The Journal of Urology, Journal of Endourology, Prostate Cancer and Prostatic Diseases and British Journal of Urology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.